Unsupported browser detected
Your browser appears to be unsupported. Because of this, portions of the site may not function as intended.
Please install a current version of Chrome, Firefox, Edge, or Safari for a better experience.
Purpose
to demonstrate the feasibility and efficacy of inhalation powder lung delivery of synthetic mRNA encoding broadly neutralizing antibodies against influenza infections in a rodent model
Grantee
Division
Global Health
Date
JUNE 2018
Region Served
GLOBAL
Committed Amount
$447,451
Grant Topic
Support Innovative Technology Solutions
Duration (Months)
15
Grantee Location
Atlanta, Georgia, United States
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.